Partnering between Large Pharmas - Does it Make Sense?

By Business Review Editor

Pharma Deals Review: Vol 2007 Issue 88 (Table of Contents)

Published: 7 Oct-2007

DOI: 10.3833/pdr.v2007.i88.281     ISSN: 1756-7874

Section: General

Fulltext:

Abstract

Abbott considers the deal with Genentech as a sensible move to bring its Phase I oncology products to market...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details